Treatment of Severe COVID-19 Infection With Remdesivir in Peritoneal Dialysis

Treatment of Severe COVID-19 Infection With Remdesivir in Peritoneal Dialysis

End-stage kidney disease (ESKD) has been shown to be correlated with an increased risk of COVID-19 infection and mortality. Remdesivir is an effective non-EUA U.S. Food and Drug Administration (FDA)-approved antiviral agent for the treatment of COVID-19 in hospitalized adult and pediatric patients,...

Full description

Bibliographic Details
Main Authors: Ryan Geffin MD, Shazia Raheem PharmD, Lavannya M. Pandit MD, MS, Andrew S. Hunter PharmD, Michael W. Holliday MD, PhD, Aditya V. Rao, Maulin K. Shah MD
Format: Article
Language:English
Published: SAGE Publishing 2023-09-01
Series:Journal of Investigative Medicine High Impact Case Reports
Online Access:https://doi.org/10.1177/23247096231200386

Similar Items

Similar Items